Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/20370
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorHerrera Ramírez, Angie Zulema-
dc.contributor.authorCastrillón López, Wilson Andrés-
dc.contributor.authorOtero Tejada, Elver Luis-
dc.contributor.authorRuíz Agudelo, Esneyder-
dc.contributor.authorCarda Usó, Pedro Miguel-
dc.contributor.authorAgut Montoliu, Raül-
dc.contributor.authorNaranjo Preciado, Tonny Williams-
dc.contributor.authorMoreno Quintero, Gustavo Alberto-
dc.contributor.authorMaldonado Celis, María Elena-
dc.contributor.authorCardona Galeano, Wilson-
dc.date.accessioned2021-06-25T02:43:33Z-
dc.date.available2021-06-25T02:43:33Z-
dc.date.issued2018-
dc.identifier.issn1054-2523-
dc.identifier.urihttp://hdl.handle.net/10495/20370-
dc.description.abstractABSTRACT: A series of styrylcoumarins were obtained via Mizoroki-Heck reactions between 3-bromo-4-methyl-7-(octyloxy)-2H-chromen-2-one or 2-oxo-2H-chromen-7-yl trifluoromethanesulfonate and functionalized styrenes. The structures of the products were elucidated by spectroscopic analysis. All compounds were evaluated against SW480 and CHO-K1 cell lines. A number of hybrids showed good antiproliferative activity. Among the tested compounds, hybrids 6e, 10c and 10d, exhibited the highest activity (IC50- SW480/48h = 6,92; 1,01 and 5,33 μM, respectively) and selectivity (IS48h = >400; 67,8 and 7,2, respectively). In addition, these compounds were able to preserve their activities over time. The results achieved by these hybrids were even better than the lead compounds (coumarin and resveratrol) and the standard drug (5-FU). As regards structure-activity relationship it seems that the location of the styryl group on the coumarin structure and the presence of the hydroxyl group on the phenyl ring were determinant for the activity.spa
dc.format.extent25spa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherSpringerspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/2.5/co/*
dc.titleSynthesis and Antiproliferative Activity of 3 and 7-Styrylcoumarinsspa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupImpacto de Componentes Alimentarios en la Saludspa
dc.publisher.groupMicología Médica y Experimentalspa
dc.publisher.groupQuímica de Plantas Colombianasspa
dc.identifier.doi10.1007/s00044-018-2202-0-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn1554-8120-
oaire.citationtitleMedicinal Chemistry Researchspa
oaire.citationstartpage1893spa
oaire.citationendpage1905spa
oaire.citationvolume27spa
oaire.citationissue1spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.publisher.placeCambridge, Inglaterraspa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTspa
dc.type.localArtículo de investigaciónspa
dc.subject.decsCumarinas-
dc.subject.decsCoumarins-
dc.subject.decsNeoplasias Colorrectales-
dc.subject.decsColorectal Neoplasms-
dc.subject.proposalStyrylcoumarinspa
dc.subject.proposalAntiproliferative activityspa
dc.identifier.urlhttps://link.springer.com/article/10.1007/s00044-018-2202-0spa
dc.description.researchgroupidCOL0015329spa
dc.description.researchgroupidCOL0013709spa
dc.description.researchgroupidCOL0083811spa
dc.relation.ispartofjournalabbrevMed. Chem. Res.spa
Aparece en las colecciones: Artículos de Revista en Ciencias Exactas y Naturales

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
HerreraAngie_2018_SynthesisAntiproloferativeStyrylcoumarins.pdfArtículo de investigación529.98 kBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons